Analyst Ratings for Aratana Therapeutics (PETX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2019 | Credit Suisse | Erin Wright | Downgrade | Neutral (Outperform) |
N/A (N/A) |
4.79 (4.92) |
2.71% | Details |
| 4/26/2019 | H.C. Wainwright | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
3.43 (4.92) |
43.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
